|
CN108299323A
|
|
A kind of novel crystal forms of anti-heart failure cocrystalization compound
|
|
CN107793320A
|
|
The method that chiral resolution prepares the butanol of 3 amino of single configuration 1
|
|
CN103304432A
|
|
Polymorphic substances of E-type lumefantrine and preparation methods thereof
|
|
CN103304431A
|
|
E type lumefantrine and preparation method thereof
|
|
CN103508973A
|
|
Efavirenz I type crystal preparation method
|
|
CN103509033A
|
|
Beta-artemether polymorphic substances and preparation methods thereof
|
|
CN103509031A
|
|
Preparation method of Darunavir amorphous matter
|
|
CN103420920A
|
|
Rilpivrine hydrochloride alcoholate polymorphs and preparation methods thereof
|
|
CN103373995A
|
|
Method for preparing pyronaridine
|
|
CN103373965A
|
|
Preparation methods of etravirine and intermediate body thereof
|
|
CN103183643A
|
|
Rilpivirine intermediate and preparation method and application thereof
|
|
CN103183642A
|
|
Intermediate used for synthesizing rilpivirine and preparation method and application in rilpivirine synthesis thereof
|
|
CN103183641A
|
|
Preparation method of rilpivirine intermediate
|
|
CN102898398A
|
|
Method for preparing type I ritonavir polymouphous crystals
|
|
CN102898399A
|
|
Method for preparing type II ritonavir polymouphous crystals
|
